Adults with overactive bladder ( OAB ) symptoms for > @ months and @ urgency urinary incontinence ( UUI ) episode and @ micturitions per @ hours at baseline were randomized to fesoterodine ( @ mg ) , tolterodine extended-release ( @ mg ) , or placebo in two @-week , double-blind , head-to-head studies .